keyword
https://read.qxmd.com/read/38619110/a-remarkable-genetic-shift-in-a-transmitted-founder-virus-broadens-antibody-responses-against-hiv-1
#21
JOURNAL ARTICLE
Swati Jain, Gherman Uritskiy, Marthandan Mahalingam, Himanshu Batra, Subhash Chand, Hung V Trinh, Charles Beck, Woong-Hee Shin, Wadad Alsalmi, Gustavo Kijak, Leigh A Eller, Jerome Kim, Daisuke Kihara, Sodsai Tovanabutra, Guido Ferrari, Merlin L Robb, Mangala Rao, Venigalla B Rao
A productive HIV-1 infection in humans is often established by transmission and propagation of a single transmitted/founder (T/F) virus, which then evolves into a complex mixture of variants during the lifetime of infection. An effective HIV-1 vaccine should elicit broad immune responses in order to block the entry of diverse T/F viruses. Currently, no such vaccine exists. An in-depth study of escape variants emerging under host immune pressure during very early stages of infection might provide insights into such a HIV-1 vaccine design...
April 15, 2024: ELife
https://read.qxmd.com/read/38619078/expert-opinion-on-antimicrobial-therapies-is-there-enough-scientific-evidence-to-state-that-targeted-therapies-outperform-non-targeted-ones
#22
REVIEW
Cristina Yus, Enrique Gámez, Manuel Arruebo
INTRODUCTION: Different active and passive strategies have been developed to fight against pathogenic bacteria. Those actions are undertaken to reduce the bacterial burden while minimizing the possibilities to develop not only antimicrobial resistance but also antimicrobial side-effects such as allergic or hypersensitivity reactions. AREAS COVERED: We have reviewed preclinical results that evidence that targeted antimicrobial therapies outperform non-targeted ones...
April 15, 2024: Expert Opinion on Drug Delivery
https://read.qxmd.com/read/38619036/current-status-of-testing-intervals-for-antiphospholipid-syndrome-testing-a-13-year-retrospective-national-data-analysis-in-south-korea
#23
JOURNAL ARTICLE
Se-Eun Koo, Jinyoung Hong, Kuenyoul Park, Seongsoo Jang
OBJECTIVE: To assess the appropriateness of laboratory testing intervals and antiphospholipid syndrome (APS) incidence. METHODS: Between January 2010 and August 2022, insurance claims data of patients with disease codes for other thrombophilia (D68.6) and APS (V253) were retrieved in South Korea. Patients who received antiphospholipid antibody tests more than twice were classified as having suspected APS. The interval between the first 2 antiphospholipid antibody tests was evaluated in the patients with suspected APS...
April 15, 2024: Laboratory Medicine
https://read.qxmd.com/read/38618959/complement-c3-and-marginal-zone-b-cells-promote-igg-mediated-enhancement-of-rbc-alloimmunization-in-mice
#24
JOURNAL ARTICLE
Arijita Jash, Thomas Pridmore, James B Collins, Ariel M Hay, Krystalyn E Hudson, Chance John Luckey, James C Zimring
Administration of anti-RhD immunoglobulin (Ig) to decrease maternal alloimmunization (antibody-mediated immune suppression [AMIS]) was a landmark clinical development. However, IgG has potent immune-stimulatory effects in other settings (antibody-mediated immune enhancement [AMIE]). The dominant thinking has been that IgG causes AMIS for antigens on RBCs but AMIE for soluble antigens. However, we have recently reported that IgG against RBC antigens can cause either AMIS or AMIE as a function of an IgG subclass...
April 15, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38618954/oncotherapy-resistance-explained-by-darwinian-and-lamarckian-models
#25
JOURNAL ARTICLE
Yogen Saunthararajah
Cell and antibody therapies directed against surface molecules on B cells, e.g., CD19-targeting chimeric antigen receptor T cells (CD19 CAR-T), are now standard for patients with chemorefractory B cell acute lymphoblastic leukemias and other B cell malignancies. However, early relapse rates remain high. In this issue of the JCI, Aminov, Giricz, and colleagues revealed that leukemia cells resisting CD19-targeted therapy had reduced CD19 but also low CD22 expression and were sensitive to Bruton's tyrosine kinase and/or MEK inhibition...
April 15, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38618895/detectable-plasma-severe-acute-respiratory-syndrome-coronavirus-2-spike-antigen-is-associated-with-poor-antibody-response-following-third-messenger-rna-vaccination-in-kidney-transplant-recipients
#26
JOURNAL ARTICLE
Andrew H Karaba, Zoe Swank, Sarah Hussain, Margaret Chahoud, Christine M Durand, Dorry L Segev, Mark A Robien, Peter S Heeger, Christian P Larsen, Aaron A R Tobian, David R Walt, William A Werbel
BACKGROUND: Kidney transplant recipients (KTRs) generate lower antibody responses to messenger RNA (mRNA)-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, yet precise mechanisms for this poor response remain uncertain. One potential contributor is suboptimal spike antigen (sAg) translation and expression owing to transplant immunosuppression, which might lead to insufficient exposure to develop humoral and/or cellular immune responses. METHODS: Within a single-arm clinical trial, 65 KTRs underwent ultrasensitive plasma sAg testing before, and 3 and 14 days after, the third mRNA vaccine doses...
April 15, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38618867/immediate-adverse-reaction-and-sars-cov-2-anti-spike-receptor-binding-domain-igg-of-covid-19-vaccines-among-health-staffs
#27
JOURNAL ARTICLE
Waleed S Rasheed, Alaa Noori Sarkees
OBJECTIVE: To contain the spread of coronavirus disease 2019 (COVID-19), several vaccines have been developed. This study is intended to elucidate the level of anti-severe acute respiratory syndrome coronavirus 2 immunoglobulin G (anti-SARS-CoV-2-IgG) antibodies for COVID-19 vaccines (Pfizer BioNTech [BNT162b2], Oxford/AstraZeneca [ChAdOx1], and Sinopharm [BBIBP-CorV]) among health staff from health facilities in Duhok province, and it explored the immediate adverse reactions of COVID-19 vaccines among participants...
April 15, 2024: Disaster Medicine and Public Health Preparedness
https://read.qxmd.com/read/38618740/efficacy-of-genotype-matched-vaccine-against-re-emerging-genotype-v-japanese-encephalitis-virus
#28
JOURNAL ARTICLE
Jae-Deog Kim, Ah-Ra Lee, Dah-Hyun Moon, Young-Uk Chung, Su-Yeon Hong, Hyo Je Cho, Tae Hyun Kang, Yo Han Jang, Myung Hyun Sohn, Baik-Lin Seong, Sang-Uk Seo
Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV), is a highly threatening disease with no specific treatment. Fortunately, the development of vaccines has enabled effective defense against JE. However, re-emerging genotype V (GV) JEV poses a challenge as current vaccines are genotype III (GIII)-based and provide suboptimal protection. Given the isolation of GV JEVs from Malaysia, China, and the Republic of Korea, there is a concern about the potential for a broader outbreak. Under the hypothesis that a GV-based vaccine is necessary for effective defense against GV JEV, we developed a pentameric recombinant antigen using cholera toxin B as a scaffold and mucosal adjuvant, which was conjugated with the E protein domain III of GV by genetic fusion...
April 15, 2024: Emerging Microbes & Infections
https://read.qxmd.com/read/38618730/current-and-future-states-of-natural-killer-cell-based-immunotherapy-in-hepatocellular-carcinoma
#29
JOURNAL ARTICLE
Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven S Raman, Anahid Jewett, Jason Chiang
Natural killer (NK) cells are innate lymphoid cells that exhibit high levels of cytotoxicity against NK-specific targets. NK cells also produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Moreover, NK cells constitute the second most common immune cell in the liver. These properties have drawn significant attention towards leveraging NK cells in treating liver cancer, especially hepatocellular carcinoma (HCC), which accounts for 75% of all primary liver cancer and is the fourth leading cause of cancer-related death worldwide...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618563/advancement-in-the-development-of-single-chain-antibodies-using-phage-display-technology
#30
JOURNAL ARTICLE
Xiaohui Zheng, Qi Liu, Yimin Liang, Wenzhi Feng, Honghao Yu, Chunyu Tong, Bocui Song
Phage display technology has become an important research tool in biological research, fundamentally changing the traditional monoclonal antibody preparation process, and has been widely used in the establishment of antigen-antibody libraries, drug design, vaccine research, pathogen detection, gene therapy, antigenic epitope research, and cellular signal transduction research.The phage display is a powerful platform for technology development. Using phage display technology, single chain fragment variable (scFv) can be screened, replacing the disadvantage of the large size of traditional antibodies...
2024: PeerJ
https://read.qxmd.com/read/38618507/the-role-of-biotechnology-in-latest-therapeutic-approaches-for-diabetes-mellitus
#31
EDITORIAL
Sepideh Hajivalizadeh, Shahin Akhondzadeh
No abstract text is available yet for this article.
2024: Avicenna Journal of Medical Biotechnology
https://read.qxmd.com/read/38618457/miller-fisher-syndrome-following-influenza-a-infection
#32
Shiho Mitsuhashi, Asuka Suzuki, Koji Hayashi, Mamiko Sato, Yuka Nakaya, Naoko Takaku, Yasutaka Kobayashi
Miller-Fisher syndrome (MFS), characterized by ophthalmoplegia, ataxia, and areflexia, is a Guillain-Barré syndrome (GBS) variant. It is well-known that the causative antibody for MFS is anti-GQ1b antibody. This report describes a rare case of MFS with not only anti-GQ1b antibodies but also anti-GT1a antibodies following Influenza A infection. The patient, a 47-year-old woman, contracted Influenza A three weeks before admission. She complained of double vision followed by areflexia, ataxia in the four extremities, and complete gaze palsy...
March 2024: Curēus
https://read.qxmd.com/read/38618444/plasmodium-falciparum-malaria-presenting-as-a-thrombotic-thrombocytopenic-purpura-ttp-mimic-a-case-report
#33
Kalendra Kunwar, Sailesh Karki, Monika Jain, Sushma Edara, James Y Rixey, Frances Schmidt
Malaria can present with clinical manifestations overlapping with thrombotic thrombocytopenic purpura (TTP). We present the case of a 55-year-old female who presented with abdominal pain, fever, confusion, dehydration, and recent travel to Nigeria. Laboratory investigations were remarkable for low hemoglobin, decreased platelets, and elevated lactate. Suspicion for TTP occurred when the patient's platelet count and hemoglobin progressively decreased along with acute kidney injury and confusion. There was an elevated ADAMTS13 antibody level and mildly reduced ADAMTS13 activity suggesting possible TTP...
March 2024: Curēus
https://read.qxmd.com/read/38618410/thymoma-exhibiting-spontaneous-regression-with-cystic-change-due-to-acute-infarction-a-case-report-and-literature-review
#34
Mikito Suzuki, Reiko Shimizu, Masahiko Harada, Tsunekazu Hishima, Hirotoshi Horio
Spontaneous regression (SR) of thymoma is rare. We report a case of a surgically resected thymoma due to cystic changes owing to acute ischemic infarction with an increased anti-acetylcholine receptor antibody level. A 61-year-old male underwent a computed tomography (CT) scan, which showed a 4.9 cm anterior mediastinal tumor and slight right pleural effusion. Blood test results indicated an elevated white blood cell count of 13300/mL. One month later, an enhanced CT scan at our hospital showed spontaneous mediastinal tumor regression to 3...
March 2024: Curēus
https://read.qxmd.com/read/38618380/anti-tif1%C3%AE-dermatomyositis-and-sj%C3%A3-gren-s-syndrome-as-the-inaugural-presentation-for-rectal-cancer
#35
Miguel Oliveira Santos, Inês Santos, Guilherme Sacramento, Rita Oliveira, Andrea Castanheira
Dermatomyositis (DM) is an inflammatory myopathy often paraneoplastic in nature. Patients have characteristic cutaneous findings and possible muscle involvement. In the latter, muscle enzymes are elevated, and the electromyogram shows varied changes. Muscle or skin biopsy and myositis-specific antibodies confirm the diagnosis. Here, we report the case of an 86-year-old woman with cutaneous lesions, proximal weakness, and sicca symptoms. Muscle enzymes and electromyogram were normal. Antinuclear antibodies were elevated, and anti-TIF1γ and anti-Ro52 antibodies were positive...
March 2024: Curēus
https://read.qxmd.com/read/38618367/clinicomycological-study-of-the-spectrum-of-pulmonary-aspergillosis-at-a-tertiary-care-hospital-in-central-india
#36
JOURNAL ARTICLE
Akshay Krishna, Archana Keche, Ranganath Tg, Padma Das
Knowing the spectrum, prevalence, and modes of diagnosis of pulmonary aspergillosis (PA) will be beneficial to clinicians for its early diagnosis and management. This study aims to estimate the prevalence, spectrum, and role of serological tests and radiological findings in the diagnosis of PA. A total of 150 patients were suspected of having PA after obtaining relevant clinical history and radiological imaging. The patients were grouped into each spectrum of PA as invasive PA (IPA), chronic necrotizing PA (CNPA), aspergilloma, allergic bronchopulmonary aspergillosis (ABPA) based on predisposing factors, clinical and radiological findings, and the guidelines of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG)...
March 2024: Curēus
https://read.qxmd.com/read/38618344/steroid-responsive-encephalopathy-associated-with-autoimmune-thyroiditis-presenting-with-parkinsonism
#37
Guemouz Hicham, Yahya Naji, Wafa Hrouch, Sara Laadami, Nawal Adali
Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) is a rare condition defined as encephalopathy with a positive antithyroid antibody. We report the case of a 52-year-old woman who presented with Parkinsonism associated with Hashimoto's thyroiditis. A few similar cases have been reported. Our patient responded well to corticosteroids with a significant reduction in symptoms. Diagnosis can pose a significant challenge in SREAT cases because of its variable clinical presentation...
March 2024: Curēus
https://read.qxmd.com/read/38618304/navigating-the-uncharted-territory-of-pediatric-onset-multiple-sclerosis-in-a-12-year-old-male-a-case-study
#38
Han Grezenko, Imam A Shah, Astri Anindya Sariza, Amna B Baluch, Ateesh Kumar, Muhammad Abubakar
This case report presents an atypical instance of pediatric-onset multiple sclerosis (MS) in a 12-year-old male, a demographic less commonly affected by this condition. The patient's clinical course was marked by severe and progressive symptoms, including lower limb weakness and loss of bowel/bladder control, diverging from the typical relapsing-remitting pattern observed in pediatric MS. Despite initial resistance to high-dose steroid treatment, his condition was ultimately stabilized through plasmapheresis, following the detection of myelin oligodendrocyte glycoprotein antibodies...
March 2024: Curēus
https://read.qxmd.com/read/38618248/antibody-platinum-iv-prodrugs-conjugates-for-targeted-treatment-of-cutaneous-squamous-cell-carcinoma
#39
JOURNAL ARTICLE
Xiangye Yin, Yingjie Zhuang, Haiqin Song, Yujian Xu, Fan Zhang, Jianxin Cui, Lei Zhao, Yingjie Yu, Qixu Zhang, Jun Ye, Youbai Chen, Yan Han
Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a typical antibody that offers the benefits of good targeting and safety for individuals with advanced and inoperable cutaneous squamous cell carcinoma (cSCC); however, its anti-tumor activity is limited to a single use...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38618208/effectiveness-of-the-sanofi-gsk-vidprevtyn-beta-and-pfizer-biontech-comirnaty-original-omicron-ba-4-5-bivalent-vaccines-against-hospitalisation-in-england
#40
JOURNAL ARTICLE
Freja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, Gavin Dabrera, Mary Ramsay, Jamie Lopez Bernal
BACKGROUND: The Sanofi/GSK AS03-adjuvanted (VidPrevtyn Beta) vaccine and the Pfizer-BioNTech mRNA (Comirnaty Original/Omicron BA.4-5) bivalent vaccine were offered to adults aged 75 years and over in England from 3rd April 2023. This is the first time an adjuvanted COVID-19 vaccine has been administered as part of a UK COVID-19 vaccination programme. In clinical trials, antibody levels generated were comparable with mRNA vaccines but there are no real-world data on the effectiveness or duration of protection...
May 2024: EClinicalMedicine
keyword
keyword
14628
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.